Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk

• DOI: 10.1371/journal.pgen.1007111
• Publication Date: 2018-02-01T18:27:15Z
• Authors: Rosalie G. Waller; Todd M. Darlington; Xiaomu Wei; Michael J. Madsen; Alun Thomas; Karen Curtin; Hilary Coon; Venkatesh Rajaman...; Justin Musinsky; David Jayabalan; Djordje Atanackovic; S. Vincent Rajkumar; Shaji Kumar; Susan Slager; Mridu Middha; Perrine Galia; Delphine Demangel; Mohamed Salama; Vijai Joseph; James McKay; Kenneth Offit; Robert J. Klein; Steven M. Lipkin; Charles Dumontet; Celine M. Vachon; Nicola J. Camp
• Keywords: Male; 0301 basic medicine; DNA Repair; DNA Mutational Analysis; Genetic Variation; QH426-470; Chromatin Assembly and Disassembly; Pedigree; 3. Good health; 03 medical and health sciences; Case-Control Studies; Databases, Genetic; Genetics; Humans; Family; Female; Genetic Predisposition to Disease; Multiple Myeloma; Research Article; Genome-Wide Association Study

ABSTRACTThe high-risk pedigree (HRP) design is an established strategy to discover rare, highly-penetrant, Mendelian-like causal variants. Its success, however, in complex traits has been modest, largely due to challenges of genetic heterogeneity and complex inheritance models. We describe a HRP strategy that addresses intra-familial heterogeneity, and identifies inherited segments important for mapping regulatory risk. We apply this new Shared Genomic Segment (SGS) method in 11 extended, Utah, multiple myeloma (MM) HRPs, and subsequent exome sequencing in SGS regions of interest in 1063 MM / MGUS (monoclonal gammopathy of undetermined significance – a precursor to MM) cases and 964 controls from a jointly-called collaborative resource, including cases from the initial 11 HRPs. One genome-wide significant 1.8 Mb shared segment was found at 6q16. Exome sequencing in this region revealed predicted deleterious variants inUSP45(p.Gln691*, p.Gln621Glu), a gene known to influence DNA repair through endonuclease regulation. Additionally, a 1.2 Mb segment at 1p36.11 is inherited in two Utah HRPs, with coding variants identified inARID1A(p.Ser90Gly, p.Met890Val), a key gene in the SWI/SNF chromatin remodeling complex. Our results provide compelling statistical and genetic evidence for segregating risk variants for MM. In addition, we demonstrate a novel strategy to use large HRPs for risk-variant discovery more generally in complex traits.AUTHOR SUMMARYAlthough family-based studies demonstrate inherited variants play a role in many common and complex diseases, finding the genes responsible remains a challenge. High-risk pedigrees, or families with more disease than expected by chance, have been helpful in the discovery of variants responsible for less complex diseases, but have not reached their potential in complex diseases. Here, we describe a method to utilize high-risk pedigrees to discover risk-genes in complex diseases. Our method is appropriate for complex diseases because it allows for genetic-heterogeneity, or multiple causes of disease, within a pedigree. This method allows us to identify shared segments that likely harbor disease-causing variants in a family. We apply our method in Multiple Myeloma, a heritable and complex cancer of plasma cells. We identified two genesUSP45andARID1Athat fall within shared segments with compelling statistical evidence. Exome sequencing of these genes revealed likely-damaging variants inherited in Myeloma high-risk families, suggesting these genes likely play a role in development of Myeloma. Our Myeloma findings demonstrate our high-risk pedigree method can identify genetic regions of interest in large high-risk pedigrees that are also relevant to smaller nuclear families and overall disease risk. In sum, we offer a strategy, applicable across phenotypes, to revitalize high-risk pedigrees in the discovery of the genetic basis of common and complex disease.